Delivery Order SPE2DR25D6028-SPE2DR26FAUFD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsule in unit dose packaging (100 count) under a firm fixed-price contract valued at $4,985.13. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,503.49 for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, firm fixed price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a typical transactional purchase under the company's...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $206,000 by the Defense Logistics Agency to provide 200mg Celecoxib capsules. The firm fixed price order is for 100 count bottles of the nonsteroidal anti-inflammatory drug and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 14, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,714.56 firm fixed-price delivery order is for the supply of Celecoxib 200mg tablets, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This delivery order, valued at $8,663.41, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Celebrex 200 mg capsules in unit dose packaging (100 count). The contract was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, under its medical supply chain operations, is the funding federal agency, and performance...
- This delivery order, valued at $2,500.73, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a contract for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory drug commonly used for pain management and arthritis treatment. The contract is firm fixed price with no set-aside designation, awarded competitively on January 23, 2026, with an ultimate completion date of January 26, 2026. Performance will be executed from the contractor's location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,197.61, is for the delivery of 4,562,868,648 capsules of the medication Celecoxib 200 mg. This is a firm fixed-price delivery order contract with an ultimate completion date of November 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award, with ID SPE2DX15D6028|SPE2DX23FWPGH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,557.27 firm fixed-price delivery order is for 4560685763 CELECOXIB 200MG 500S, a pharmaceutical product. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Celecoxib 200 mg capsules. The contract has a ceiling value of $20,786.08 and a completion date of September 11, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this prescription medication to support military treatment facilities,...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAUFDDelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Celecoxib 200mg in quantities of 500 on January 23, 2026, by the Defense Logistics Agency (DLA). This firm fixed-price, competitively awarded contract has a ceiling value of $1,012.86 with an ultimate completion date of February 20, 2026. The delivery order was placed under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. No set-aside designation was used for this award. Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for pain management and inflammation reduction in military medical treatment facilities and veteran healthcare systems. This delivery order represents a routine pharmaceutical procurement through Amerisourcebergen Drug Corp's established relationship with DLA, leveraging the company's extensive portfolio of brand-name and generic medications to support federal medical supply needs. The parent organization, Cencora, Inc. (doing business as Amerisourcebergen), maintains significant pharmaceutical distribution contracts across multiple federal agencies and holds an even larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/22/26 |